Skip to content
DataLookout
Menu

NCT07906054

Ultra-high-performance Positron Emission Tomography (PET) of Synaptic Density, Reactive Astrogliosis and Tau in Alzheimer's Disease

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Start date pushed from Oct 2026 to Dec 2026
    • Study completion moved earlier from Oct 2029 to Jun 2029
  2. Notable Primary endpoint(s) modified
    • Secondary endpoints revised (3)
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

The correlation between tau, synaptic density and reactive astrogliosis
Timeframe: Baseline
Changes in synaptic density, tau and reactive astrolgiosis between AD patients, controls and centenarians
Timeframe: Baseline

Secondary (3)

Correlation of synaptic density, tau and reactive astrogliosis with diffusion MRI
Correlation of synaptic density, tau and reactive astrogliosis with blood-based biomarkers
Correlation of synaptic density, tau and reactive astrogliosis with cognitive performance

Arms and interventions

Patients with AD
Healthy control participants
Centenarians

Other: 18F-SMBT-1 PET, 18F-SynVesT-1 PET, 18F-MK-6240 PET

Sites

1 site in 1 country

  • University Hospitals LeuvenLeuven, Vlaams-Brabant, Belgium